La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Amedisys Bilan de santé
Santé financière contrôle des critères 6/6
Amedisys possède un total de capitaux propres de $1.2B et une dette totale de $358.6M, ce qui porte son ratio d'endettement à 30.4%. Son actif total et son passif total sont $2.1B et de $938.5M. L'EBIT de Amedisys est $209.1M ce qui fait que son ratio de couverture des intérêts 7.8. Elle dispose de liquidités et de placements à court terme de $149.9M.
Informations clés
30.4%
Ratio d'endettement
US$358.59m
Dette
| Ratio de couverture des intérêts | 7.8x |
| Argent liquide | US$149.88m |
| Fonds propres | US$1.18b |
| Total du passif | US$938.48m |
| Total des actifs | US$2.12b |
Mises à jour récentes de la santé financière
Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?
Feb 25
We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt
Jul 20Is Amedisys (NASDAQ:AMED) A Risky Investment?
Feb 20These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely
Nov 18Amedisys (NASDAQ:AMED) Could Easily Take On More Debt
Aug 18Recent updates
Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 41% Discount?
Apr 10Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?
Feb 25Amedisys (NASDAQ:AMED) Will Be Hoping To Turn Its Returns On Capital Around
Feb 10At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jan 03A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Dec 16Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal
Nov 12Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?
Sep 19An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued
Sep 04Amedisys: ROIC, Tangible Book Value Each Softening
Aug 24Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement
Aug 04Amedisys profit beats by $0.24, revenue misses by $25.23M, 2022 guidance below estimates
Jul 27We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt
Jul 20At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jun 04Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled
May 05Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?
Apr 20Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?
Apr 06Is Amedisys (NASDAQ:AMED) A Risky Investment?
Feb 20Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue
Jan 19Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
Dec 03These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely
Nov 18Amedisys (NASDAQ:AMED) Could Easily Take On More Debt
Aug 18Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Jul 23Amedisys: Strategic Contessa Acquisition Underpins The Home Healthcare Growth Opportunity
Jul 18Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive
Jun 28It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package
Jun 02Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
May 24Analyse de la situation financière
Passif à court terme: Les actifs à court terme de AMED ( $555.9M ) dépassent ses passifs à court terme ( $480.0M ).
Passif à long terme: Les actifs à court terme de AMED ( $555.9M ) dépassent ses passifs à long terme ( $458.5M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de AMED ( 17.7% ) est considéré comme satisfaisant.
Réduire la dette: Le ratio d'endettement de AMED a été réduit de 48.1% à 30.4% au cours des 5 dernières années.
Couverture de la dette: La dette de AMED est bien couverte par le flux de trésorerie opérationnel ( 26.8% ).
Couverture des intérêts: Les paiements d'intérêts de AMED sur sa dette sont bien couverts par l'EBIT ( 7.8 x couverture).